CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.56
−1.79%Margins
Gross margin
-521.7%
EBITDA margin
-3621.7%
EBIT margin
-3900.9%
Net margin
-3934.9%
FCF margin
-3679.6%
-424.9%
Return on equity
-173.9%
Return on assets
-221.3%
Return on invested capital
0.04x
Asset turnover
-$11.6M
Cash from operations
$1.56
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026